biocon.com stats and valuation
Basic Information
| Created | 1996-03-10 |
| Updated | 2019-01-11 |
| Expires | 2022-03-11 |
| Registrar | Network Solutions, LLC |
| Alexa Rank | 278448 |
| Backlinks | 0 |
| Domain Authority | 0/100 |
| Pageviews | 3.95K/ Day |
| Worth | 8.65K |
Website Information
- Title
- Biocon - India's largest biopharmaceutical company
- google-site-verification
- xNXPVchHbX2dCS2LHgqv3OtvZC10-piQtxEJV-pecRk
- copyright
- Biocon website is registered by Biocon Limited. Copy right & copy 2007 - 2015, All rights
- description
- Biocon is an innovation led fully integrated biopharmaceutical company that has developed affordable biosimilars, novel biologics and complex APIs. Leader in fermentation based biopharmaceuticals. Global scale manufacturing set up for biologics, biosimilars. High end scientific talent, research and development infrastructure. Largest Indian insulins company. Rich pipeline of biosimilars with nine products and novel biologics at various stages of clinical development including a high potential oral insulin. Novel Biologics, Biosimilars, Fermentation based APIs, statins, Tacrolimus, Sirolimus, Everolimus, Human Insulin, Glargine, Immunosuppresants, Monoclonal Antibody, Recombinant Proteins, Generic formulations, Trastuzumab, Itolizumab, Nimotuzamab, BioMab EGFR, Biopharmaceutical, Biotechnology Company, EGFR, GCSF, Fermentation, Orlistat, Insulin Lispro, Peptides, Insulin Aspart, diabetes, cancer, oncology, autoimmune, breast cancer, head neck cancer, psoriasis, chronic disease
- keywords
- Biocon, best biopharma company, top biopharma company, Biologics, Research services, Head and neck cancer, breast cancer, cancer drugs, clinical trials, Research, innovation, Contract Manufacturing, affordable medicines, affordable drugs, medical, biocon share market price, pharma, Biologics, biotech, biotechnology, pharmaceuticals, biopharmaceuticals, diabetes, insulin, insulin analogs, human insulin, oral insulin, immunosuppressant, immunotherapy, Psoriasis, DNA, RNA, Bio product, Research Services, Branded Formulations, Biosimilar, Small Molecules, fermentation, monoclonal antibody, recombinant proteins, egfr, gcsf, orlistat, glargine, peptides, Aspart, Lispro, Monoclonal Antibody, metabolic, drug, drug manufacturing, stalins, Orlistat, Peptides, Pharmaceutical Contract Manufacturing, large scale producers, global manufacturers, Biotech, APIs, Formulations, Injectable, Discovery, small molecules, Novel Molecules, Recombinant Proteins, fusion proteins, Integrated Branded Formulations, diabetology, oncology, nephrology, cardiology, comprehensive care, Insugen, Basalog, Canmab, Tacrograf, Biomab EGFR, Renodapt S, Psorid, Cimivir L, Renodapt, Insugen N, Daclawin, Tbis, Picon, Cymgal, Calpsor C, Abstet, Thinla, Evertor, Advacan, Rapacan, Aretha, Bionesp, Fosaport, Genxtor, Calpsor, Inter acting, fast acting, Long acting, Trastuzumab recombinant, Tacrolimus, Oth mab antineoplastics, Mycophenolic acid, Ciclosporin, Ledipasvir, sofosbuvir, Mycophenolate mofetil, Intermediate acting, Daclatasvir, Tacrolimus topical, Pimecrolimus, Valganciclovir, Oth clobetasol, antiinf co, Abiraterone, Heparin, Everolimus, Sirolimus, Azathioprine, Darbepoetin prep, Fosaprepitant meglumine, Oth pki antineoplastics, Calcipotriol
- robots
- ALL
- dc.title
- Biocon is India's largest and fully-integrated, innovation-led biopharmaceutical company. As an emerging global biopharmaceutical enterprise we serve our customers and partners in over 100 countries. We are committed to reduce therapy costs of chronic diseases like autoimmune, diabetes, and cancer.
- distribution
- global
- rating
- general
- Important Html Tags
- H1 0
- H2 0
- H3 0
- H4 0
- STRONG 55
- A 60
- IMG 58
- Page Size
- 64Kb
- Code to Text Ratio
- 14.8% (Text size 9.47Kb and Code size 54.53Kb)
- Http Header
HTTP/1.1 200 OK Cache-Control: private Content-Type: text/html Server: Microsoft-IIS/8.5 Set-Cookie: ASPSESSIONIDCCRSAQAA=KMBONBPCPNOPPKHMJCGDOGBF; path=/ X-Frame-Options: SAMEORIGIN Date: Fri, 17 May 2019 07:00:54 GMT Content-Length: 71201
